SSCB Stem Cell Bank

Swiss Stem Cell Bank (SSCB) is a leading private biobank based in Lugano, Switzerland, specializing in the collection, processing, and cryopreservation of stem cells from umbilical cord blood and tissue. Established in 2005, it was the first private laboratory in Switzerland to receive the international FACT-NetCord accreditation, ensuring the highest quality standards for clinical applications. The company provides families with long-term storage solutions for newborn stem cells, which can be used in the treatment of various hematological, oncological, and metabolic disorders. SSCB operates under Swissmedic authorization and follows strict Good Manufacturing Practice (GMP) guidelines. In 2019, the company was acquired by the FamiCord Group, which later merged with Vita 34 to form the largest stem cell banking network in Europe. This integration allows SSCB to offer its clients access to advanced regenerative medicine therapies and a vast network of clinical expertise.